What is the current Poloxamer market size?

The Poloxamer market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Poloxamer market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Poloxamer market?

Increasing demand from pharmaceutical and cosmetic industries drives the Poloxamer market.

What are the challenges facing the Poloxamer market?

Fluctuating raw material prices and stringent regulations challenge the Poloxamer market.

Which regions lead the Poloxamer market?

North America and Europe are the leading regions in the Poloxamer market.

Who are the top companies in the Poloxamer market?

BASF and Dow Chemical are among the top companies in the Poloxamer market.

What are the future opportunities in the Poloxamer market?

Growing demand from emerging economies presents future opportunities for the Poloxamer market.

How does technology impact the Poloxamer market?

Advances in manufacturing technology improve efficiency and reduce costs in the Poloxamer market.

What is the regulatory landscape for the Poloxamer market?

Regulations from agencies like the FDA and EU's ECHA shape the Poloxamer market.

What is the future outlook for the Poloxamer market?

The future outlook for the Poloxamer market is positive, driven by increasing demand.

Poloxamer Market Metrics & Forecast Analysis 2033

Poloxamer by Application (Pharmaceutical Industry, Cosmetics Industry, Biologics, Others), by Types (Poloxamer 124, Poloxamer 188, Poloxamer 338, Poloxamer 407, Poloxamer 184, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $244 million

CAGR: 3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $244 million

CAGR: 3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Poloxamer Market Overview

The Poloxamer market refers to the global industry involved in the production and distribution of Poloxamer, a type of nonionic triblock copolymer. As a significant sector in the chemical industry, the Poloxamer market size is estimated to be around $1.4 billion. The growth outlook for the Poloxamer market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2026 to 2033, driven by factors such as increasing demand from the pharmaceutical and cosmetic industries. The industry expansion is expected to be shaped by key forces such as technology shifts, regulations, and consumer behavior, with the largest region being North America and the fastest-growing region being Asia-Pacific.

Loading chart…

The Poloxamer market is expected to experience significant growth due to its increasing applications in various industries. The macro drivers of the market include the growing demand for Poloxamer in the pharmaceutical industry, particularly in the production of vaccines and other biological products. Additionally, the rising demand for Poloxamer in the cosmetic industry, driven by its use in skincare and haircare products, is also expected to contribute to the market's growth. The key forces shaping the industry include technology shifts, such as the development of new production methods, and regulations, such as those related to the use of Poloxamer in pharmaceutical and cosmetic products. Overall, the Poloxamer market is expected to experience significant growth and industry expansion in the coming years, driven by its increasing applications and demand from various industries.

Report Overview

Report Attribute	Details
Market size value in 2025	244.00 million
Revenue forecast in 2033	425.55 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BASF; Croda; Hubei Hengshuo; ADEKA; Solvay; Lakeland Chemicals; Nanjing Well; Merck KGaA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Poloxamer market is witnessing significant growth, driven by increasing demand from various end-use industries. The market dynamics are shaped by several factors, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Rising demand for Poloxamer in the pharmaceutical industry, particularly in the development of controlled-release formulations, is driving the market growth. The unique properties of Poloxamer, such as its ability to form micelles and solubilize hydrophobic compounds, make it an ideal excipient in drug delivery systems.

Growing applications of Poloxamer in the cosmetic industry, including its use in skin care products and personal care products, are also contributing to the market growth. The growth forecast for the Poloxamer market size is expected to be positive, driven by increasing demand from these end-use industries.

Restraints2 items

Stringent regulations and guidelines set by regulatory authorities, such as the FDA, may hinder the growth of the Poloxamer market. The regulatory environment can impact the development and commercialization of new products, affecting the market size and growth forecast.

Fluctuations in raw material prices and availability can also affect the production costs and supply chain of Poloxamer, thereby restraining the market growth. The Poloxamer market size can be impacted by these factors, making it essential to monitor the market dynamics closely.

Opportunities2 items

Increasing demand for sustainable and biodegradable products is creating opportunities for the development of new Poloxamer-based products. The use of Poloxamer in environmentally friendly applications can drive the market growth and contribute to the overall growth forecast of the Poloxamer market.

Growing investments in research and development activities, particularly in the pharmaceutical and cosmetic industries, are expected to lead to the development of new applications for Poloxamer, further driving the market growth. The Poloxamer market is expected to witness significant growth in the coming years, driven by these opportunities.

Challenges2 items

Intense competition in the Poloxamer market can make it challenging for new entrants to establish themselves. The market is dominated by a few large players, making it essential for new companies to develop innovative products and strategies to compete effectively.

The Poloxamer market size can be impacted by macroeconomic factors, such as economic downturns and trade wars, which can affect the demand for Poloxamer and the overall market growth. It is essential to monitor these factors closely and develop strategies to mitigate their impact on the market.

Market Segmentation

Loading chart…

The Application segment of the Poloxamer market is a crucial aspect of Poloxamer segmentation, as it defines the various uses of Poloxamer in different industries. This segment includes subtypes such as pharmaceuticals, cosmetics, and industrial applications. Each subtype contributes to the overall Poloxamer market size, with pharmaceuticals being the largest consumer of Poloxamer due to its use as an excipient in drug formulations.

The Types segment of the Poloxamer market is another essential aspect of market taxonomy, as it categorizes Poloxamer into different types based on their molecular weight and composition. This segment includes subtypes such as Poloxamer 124, Poloxamer 188, and Poloxamer 407, each with its unique properties and applications. Understanding these subtypes is crucial for analyzing the Poloxamer market, as they have different market demands and growth prospects.

Poloxamer Segmentation Breakdown12 items

Application

Pharmaceutical Industry

Cosmetics Industry

Biologics

Others

Types

Poloxamer 124

Poloxamer 188

Poloxamer 338

Poloxamer 407

Poloxamer 184

Others

Regional Insights

Loading chart…

The Poloxamer market growth is expected to be driven by various factors across different regions. The largest region, Asia Pacific, accounts for approximately 40% of the market share, driven by key drivers such as increasing adoption of Poloxamer in the pharmaceutical industry, government policies supporting the growth of the healthcare sector, and significant investments in research and development. On the other hand, North America is the fastest-growing region, with a growth rate driven by factors such as a mature ecosystem, high demographics of the aging population, and advanced infrastructure.

In Europe, the Poloxamer market growth is driven by factors such as strict regulations and standards, a strong pharmaceutical industry, and a high level of awareness about the benefits of Poloxamer. Latin America is driven by factors such as increasing demand for Poloxamer in the cosmetics industry, growing healthcare expenditure, and improving infrastructure. Meanwhile, the Middle East & Africa region is driven by factors such as growing investment in the pharmaceutical sector, increasing adoption of Poloxamer in the oil and gas industry, and a rising middle-class population.

Regional Forecast5 items

Asia Pacific: 40% market share, driven by adoption, policies, and investments

North America: fastest-growing region, driven by ecosystem maturity, demographics, and infrastructure

Europe: driven by regulations, pharmaceutical industry, and awareness

Latin America: driven by demand, healthcare expenditure, and infrastructure

Middle East & Africa: driven by investment, adoption, and middle-class population

Competitive Landscape

The Poloxamer market is moderately consolidated, driven by a mix of global players and local/regional companies. The Poloxamer competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and certifications, while local companies concentrate on pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages. Key players in the market include:

BASF: regional expansion

Croda: premium pricing

Hubei Hengshuo: local manufacturing

ADEKA: innovation pipeline

Solvay: OEM tie-ups

Lakeland Chemicals: vertical integration

Key Poloxamer Companies8 items

BASF

Croda

Hubei Hengshuo

ADEKA

Solvay

Lakeland Chemicals

Nanjing Well

Merck KGaA

Market Ecosystem

The Poloxamer ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of Poloxamer products, with each participant playing a distinct role in the Poloxamer ecosystem. The ecosystem's boundaries are defined by the flow of materials, technologies, and services from raw material suppliers to end users, with various intermediaries facilitating the creation and delivery of value.

Raw material suppliers — provide Poloxamer precursors

OEMs / manufacturers — produce Poloxamer products

Technology providers — develop Poloxamer-related technologies

Distributors / channel partners — distribute Poloxamer products

System integrators / EPCs — integrate Poloxamer into larger systems

Service providers / after-sales — offer support and maintenance services

Regulators/standards bodies — establish Poloxamer standards and guidelines

The flow of value in the Poloxamer ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can influence the relationships between participants, with regional differences in the ecosystem potentially leading to varying levels of complexity and competition. Understanding these dynamics is essential for conducting a comprehensive value chain analysis of the Poloxamer market.

Recent Industry Insights

The Poloxamer industry trends have witnessed significant developments over the last 12-18 months, driven by strategic partnerships, mergers, and acquisitions. Notably, key players have formed alliances to enhance their product portfolios and expand their market presence. Furthermore, there have been notable product launches, focusing on innovative applications of Poloxamer in pharmaceuticals and personal care products.

Recent regulatory changes have also influenced the Poloxamer market, with a shift towards more stringent quality standards. Additionally, funding rounds and expansions have been observed, indicating a growing interest in the Poloxamer industry. These developments underscore the evolving nature of the Poloxamer market, with companies adapting to changing consumer and enterprise trends, ultimately shaping the future of the Poloxamer industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Poloxamer market outlook. The market attractiveness is moderate, driven by growing demand from pharmaceutical and cosmetic applications. Competitive intensity is high, with key players competing on price, quality, and innovation. The long-term outlook is positive, with increasing adoption in emerging markets and new applications.

The innovation landscape is evolving, with a focus on sustainable and bio-based Poloxamer products. However, the demand-supply balance is a key concern, with fluctuations in raw material prices and supply chain disruptions. Key risk factors include regulatory changes, trade policies, and environmental concerns. Overall, the Poloxamer market is expected to experience steady growth, driven by its unique properties and increasing demand from various end-use industries.

12 items

1. Executive Summary

2. Poloxamer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Poloxamer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Poloxamer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Poloxamer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Poloxamer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Poloxamer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Poloxamer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Poloxamer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Poloxamer Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Poloxamer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Poloxamer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Poloxamer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Poloxamer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Poloxamer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Poloxamer Market Competition by Key Manufacturers

9.1. Global Poloxamer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Poloxamer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BASF

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Croda

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Hubei Hengshuo

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ADEKA

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Solvay

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Lakeland Chemicals

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Nanjing Well

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Merck KGaA

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Poloxamer Market

Figure 4: Global Poloxamer Market: Drivers

Figure 5: Global Poloxamer Market: Challenges

Figure 6: Global Poloxamer Market: Trends

Figure 7: Global Poloxamer Market: Opportunity

Figure 8: Global Poloxamer Market: Restraint

Figure 9: Global Poloxamer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Poloxamer Market Value (USD Million) By Region

Figure 19: Global Poloxamer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Poloxamer Market Value (USD Million) By Region

Figure 27: Global Poloxamer Market Share (%) By: Regions (2032)

Figure 28: Global Poloxamer Market Volume (K) By Region

Figure 29: Global Poloxamer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Poloxamer Market Value (USD Million) By Region

Figure 37: Global Poloxamer Market Share (%) By: Regions (2032)

Figure 38: Global Poloxamer Market Volume (K) By Region

Figure 39: Global Poloxamer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Poloxamer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Poloxamer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Poloxamer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Poloxamer Market Value (USD Million) By Region

Table 14: Global Poloxamer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Poloxamer Market Volume (K) By Region

Table 31: Global Poloxamer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Poloxamer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Poloxamer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Poloxamer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BASF Basic Information And Sales Area

Table 52: BASF. Products Portfolio

Table 53: Croda Basic Information And Sales Area

Table 54: Croda. Products Portfolio

Table 55: Hubei Hengshuo Basic Information And Sales Area

Table 56: Hubei Hengshuo. Products Portfolio

Table 57: ADEKA Basic Information And Sales Area

Table 58: ADEKA. Products Portfolio

Table 59: Solvay Basic Information And Sales Area

Table 60: Solvay. Products Portfolio

Table 61: Lakeland Chemicals Basic Information And Sales Area

Table 62: Lakeland Chemicals. Products Portfolio

Table 63: Nanjing Well Basic Information And Sales Area

Table 64: Nanjing Well. Products Portfolio

Table 65: Merck KGaA Basic Information And Sales Area

Table 66: Merck KGaA. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Poloxamer Market Value (USD Million) By Region

Table 76: Global Poloxamer Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Poloxamer Market Volume (K) By Region

Table 93: Global Poloxamer Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Poloxamer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	244.00 million
Revenue forecast in 2033	425.55 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BASF; Croda; Hubei Hengshuo; ADEKA; Solvay; Lakeland Chemicals; Nanjing Well; Merck KGaA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Poloxamer Segmentation Breakdown12 items

Application

Pharmaceutical Industry

Cosmetics Industry

Biologics

Others

Types

Poloxamer 124

Poloxamer 188

Poloxamer 338

Poloxamer 407

Poloxamer 184

Others

Regional Insights

Loading chart…

Regional Forecast5 items

Asia Pacific: 40% market share, driven by adoption, policies, and investments

North America: fastest-growing region, driven by ecosystem maturity, demographics, and infrastructure

Europe: driven by regulations, pharmaceutical industry, and awareness

Latin America: driven by demand, healthcare expenditure, and infrastructure

Middle East & Africa: driven by investment, adoption, and middle-class population

Competitive Landscape

BASF: regional expansion

Croda: premium pricing

Hubei Hengshuo: local manufacturing

ADEKA: innovation pipeline

Solvay: OEM tie-ups

Lakeland Chemicals: vertical integration

Key Poloxamer Companies8 items

BASF

Croda

Hubei Hengshuo

ADEKA

Solvay

Lakeland Chemicals

Nanjing Well

Merck KGaA

Market Ecosystem

Raw material suppliers — provide Poloxamer precursors

OEMs / manufacturers — produce Poloxamer products

Technology providers — develop Poloxamer-related technologies

Distributors / channel partners — distribute Poloxamer products

System integrators / EPCs — integrate Poloxamer into larger systems

Service providers / after-sales — offer support and maintenance services

Regulators/standards bodies — establish Poloxamer standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents